参考文献/References:
［1］ van den Berg JC. In-stent restenosis management： the best is yet to come［J］. Torino， 2017， 58： 508-517.
［2］ 吴丹明，沈世凯． 股腘动脉腔内治疗后再狭窄的处理［J］． 中国血管外科杂志（电子版）， 2016， 8：97-100．
［3］ Tosaka A， Soga Y， Iida O， et al. Classification and clinical impact of restenosis after femoropopliteal stenting［J］. J Am Coll Cardiol， 2012， 59： 16-23.
［4］ Werner M. Drug eluting stents and modern stent technologies for in- stent restenosis［J］. J Cardiovasc Surg（Torino）， 2017， 58： 497-500.
［5］ Bague N， Julia P， Sauguet A， et al. Femoropopliteal in- stent restenosis repair： midterm outcomes after paclitaxel eluting balloon use（PLAISIR trial）［J］. Eur J Vasc Endovasc Surg， 2017， 53： 106-113.
［6］ Dick P， Sabeti S， Mlekusch W， et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in- stent restenosis： initial experience［J］. Radiology， 2008， 248： 297-302.
［7］ Schmidt A， Zeller T， Sievert H， et al. Photoablation using the turbo- booster and excimer laser for in-stent restenosis treatment： twelve-month results from the PATENT study［J］. J Endovasc Ther， 2014， 21： 52- 60.
［8］ Jayasuriya S， Ward C， Mena- Hurtado C. Role of laser atherectomy for the management of in- stent restenosis in the peripheral arteries［J］. J Cardiovasc Surg（Torino）， 2014， 55： 339-345.
［9］ Stanek F. Laser angioplasty of peripheral arteries： basic principles， current clinical studies， and future directions［J］. Diagn Interv Radiol， 2019， 25： 392-397.
［10］ Tai Z. Excimer laser in contrast for the treatment of acute MI caused by thrombosis of underexpanded stent［J］. Clin Case Rep， 2018， 6： 1457-1463.
［11］ Bosiers M， Peeters P， Elst FV， et al. Excimer laser assisted angioplasty for critical limb ischemia： results of the LACI Belgium study［J］. Eur J Vasc Endovasc Surg， 2005， 29： 613-619.
［12］ Dippel EJ， Makam P， Kovach R， et al. Randomized controlled study of excimer laser atherectomy for treatment of femoro-popliteal in- stent restenosis： initial results from the EXCITE ISR trial（EXCImer Laser Randomized Controlled Study for Treatment of Femoropopliteal in- Stent Restenosis）［J］. JACC Cardiovasc Interv， 2015， 8（1 Pt A）： 92-101.
［13］ Charalambous N， Schafer PJ， Trentmann J， et al. Percutaneous intraluminal recanalization of long， chronic superficial femoral and popliteal occlusions using the Frontrunner XP CTO device： a single- center experience［J］. Cardiovasc Intervent Radiol， 2010， 33： 25-33.
［14］ Serino F， Cao Y， Renzi C， et al. Excimer laser ablation in the treatment of total chronic obstructions in critical limb ischaemia in diabetic patients. Sustained efficacy of plaque recanalisation in mid- term results［J］. Eur J Vasc Endovasc Surg， 2010， 39： 234-238.
［15］ Savastano LE， Zhou Q， Smith A， et al. Multimodal laser-based angioscopy for structural， chemical and biological imaging of atherosclerosis［J］. Nat Biomed Eng， 2017， 1： 0023.
［16］ Ramkumar N， Martinez-Camblor P， Columbo JA， et al. Adverse events after atherectomy： analyzing long- term outcomes of endovascular lower extremity revascularization techniques［J］. J Am Heart Assoc， 2019， 8： e012081.
［17］ Armstrong EJ， Thiruvoipati T， Tanganyika K， et al. Laser atherectomy for treatment of femoropopliteal in- stent restenosis［J］. J Endovasc Ther， 2015， 22： 506-513.
［18］ Kokkinidis DG， Armstrong EJ. Current developments in endovas- cular therapy of peripheral vascular disease［J］. J Thorac Dis， 2020， 12： 1681-1694.
［19］ Hajibandeh S， Hajibandeh S， Antoniou S， et al. Treatment strategies for in- stent restenosis in peripheral arterial disease： a systematic review［J］. Interact Cardiovasc Thorac Surg， 2019， 28： 253-261.
［20］ Piyaskulkaew C， Parvataneni K， Ballout H， et al. Laser in infrapopliteal and popliteal stenosis 2 study（LIPS2）： long-term outcomes of laser-assisted balloon angioplasty versus balloon angioplasty for below knee peripheral arterial disease［J］. Catheter Cardiovasc Interv， 2015， 86： 1211-1218.
［21］ Dave RM， Patlola R， Kollmeyer K， et al. Excimer laser recana- lization of femoropopliteal lesions and 1-year patency： results of the CELLO registry［J］. J Endovasc Ther， 2009， 16： 665- 675.
［22］ Granada JF， Milewski K， Zhao H， et al. Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic Swine［J］. Circ Cardiovasc Interv， 2011， 4： 447-455.
［23］ Ong PJL， Kubo T， Watson TJ， et al. Angiographic， optical coherence tomography and histology findings from combination of a drug- coated balloon with an everolimus- eluting stent in a porcine model［J］. Int J Cardiol， 2016， 223：665-668.
［24］ Schmehl J， von der Ruhr J， Dobratz M， et al. Balloon coating with rapamycin using an on-site coating device［J］. Cardiovasc Intervent Radiol， 2013， 36： 756-763.
［25］ Woehrle J. Drug-coated balloons for coronary and peripheral interventional procedures［J］. Curr Cardiol Rep， 2012， 14： 635-641.
［26］ Tepe G， Schroeder H， Albrecht T， et al. Paclitaxel- coated balloon vs uncoated balloon angioplasty for treatment of in-stent restenosis in the superficial femoral and popliteal arteries： the COPA CABANA trial［J］. J Endovasc Ther， 2020， 27： 276-286.
［27］ 刘晓哲，王 兵，刘俊超，等． 药物涂层球囊在股腘动脉支架内再狭窄治疗中的应用［J］． 介入放射学杂志， 2018， 27：410- 414．
［28］ 项以力，张温凯，杨 镛． 药物涂层球囊和无涂层球囊治疗股腘动脉缺血性疾病疗效及安全性meta分析［J］． 介入放射学杂志， 2017， 26：500-507．
［29］ Liistro F， Angioli P， Porto I， et al. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries： the DEBATE-ISR study［J］. J Endovasc Ther， 2014， 21： 1- 8.
［30］ Kokkinidis DG， Hossain P， Jawaid O， et al. Laser atherectomy combined with drug-coated balloon angioplasty is associated with improved 1-year outcomes for treatment of femoro- popliteal in-stent restenosis［J］. J Endovasc Ther， 2018， 25： 81-88.
［31］ 谷涌泉，郭连瑞，齐立行，等． 准分子激光消蚀联合药物涂层球囊治疗下肢动脉硬化闭塞20例［J］． 介入放射学杂志， 2018， 27：779-782．
［32］ 李 杨，黄 莹，郭连瑞，等． 准分子激光消蚀联合药物涂层球囊治疗股腘动脉支架内再狭窄的临床疗效［J］． 中华老年心脑血管病杂志， 2019， 21：934-938．
［33］ Gandini R， Del Giudice C， Merolla S， et al. Treatment of chronic SFA in- stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia： a single- center， prospective， randomized study［J］. J Endovasc Ther， 2013， 20： 805-814.
［34］ Katsanos K， Spiliopoulos S， Reppas L， et al. Debulking atherectomy in the peripheral arteries： is there a role and what is the evidence?［J］. Cardiovasc Intervent Radiol， 2017， 40： 964-977.
相似文献/References:
[1]王建红,郭富强.支架内再狭窄的发病机制研究[J].介入放射学杂志,2008,(10):754.
WANG Jianhong,GUO Fuqiang.Study on pathogenesis for in－stent restenosis[J].journal interventional radiology,2008,(05):754.
[2]刘小希,邹 文,孟刘坤,等.急性冠状动脉综合征患者PCI术后受体相互作用蛋白激酶1表达及其与支架内再狭窄的关系 [J].介入放射学杂志,2021,30(05):438.
LIU Xiaoxi,ZOU Wen,MENG Liukun,et al.The expression level of receptor-interacting protein kinase 1 in patients with acute coronary syndrome after PCI and its relationship with in-stent restenosis[J].journal interventional radiology,2021,30(05):438.
[3]张 克,杨 涛,郝 斌.下肢动脉硬化闭塞症患者支架植入术后血清miR- 140- 5p与1年内支架内再狭窄相关性研究[J].介入放射学杂志,2022,31(06):555.
ZHANG Ke,YANG Tao,HAO Bin..Correlation between serum microRNA-140-5p level and in-stent restenosis occurring within one year after interventional treatment in patients with lower extremity atherosclerotic occlusive disease[J].journal interventional radiology,2022,31(05):555.
[4]梁广财,黄 珊,施 磊,等.颈动脉支架内再狭窄研究进展[J].介入放射学杂志,2023,32(04):396.
LIANG Guangcai,HUANG Shan,SHI Lei,et al.Research progress in carotid artery in-stent restenosis[J].journal interventional radiology,2023,32(05):396.